Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol

Carcinogenesis

Volumn 26, Issue 9, 2005, Pages 1573-1580

  Powley, M W ^b   Li, Y ^b   Upton, P B ^b   Walker, V E ^a   Swenberg, James A ^b  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; 1,3 BUTADIENE DERIVATIVE; 3 BUTENE 1,2 DIOL; 3,4 EPOXY 1,2 BUTANEDIOL; GUANINE DERIVATIVE; HEMOGLOBIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DNA ADDUCT; DOSE RESPONSE; DOSIMETRY; FEMALE; HEMOGLOBIN DETERMINATION; LIVER; LUNG; MOUSE; MUTAGENICITY; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; STATISTICAL SIGNIFICANCE; TARGET ORGAN;

ANIMALS; DNA; DNA ADDUCTS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLYCOLS; HEMOGLOBINS; LIVER; LUNG; MICE; MICE, INBRED STRAINS; RATS; RATS, INBRED F344; SPECIES SPECIFICITY; VALINE;

EID: 24144498466     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgi119     Document Type: Article

References (52)

1. Huff,J.E., Melnick,R.L., Solleveld,H.A., Haseman,J.K., Powers,M. and Miller,R.A. (1985) Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science, 227 548-549.
2. Melnick,R.L., Huff,J., Chou,B.J. and Miller,R.A. (1990) Carcinogenicity of 1,3-butadiene in C57BL/6 × C3HF1 mice at low exposure concentrations. Cancer Res., 50, 6592-6599.
3. Melnick,R.L., Huff,J.E., Roycroft,J.H., Chou,B.J. and Miller,R.A. (1990) Inhalation toxicology and carcinogenicity of 1,3-butadiene in B6C3F1 mice following 65 weeks of exposure. Environ. Health Perspect., 86, 27-36.
4. Owen,P.E., Glaister,J.R., Graunt,I.F. and Pullinger,D.H. (1987) Inhalation toxicity studies with 1,3-butadiene. 3. Two-year toxicity/ carcinogenicity study in rats. Am. Ind. Hyg. Assoc. J., 48, 407-413.
5. Owen,P.E. and Glaister,J.R. (1990) Inhalation toxicity and carcinogenicity of 1,3-butadiene in Sprague-Dawley rats. Environ. Health Perspect., 86, 19-25.
6. Delzell,E., Sathiakumar,N., Hovinga,M., Macaluso,M., Julian,J., Larson,R., Cole,P. and Muir,D.C.F. (1996) A follow-up study of synthetic rubber workers. Toxicology, 113, 182-189.
7. Divine,B.J. and Hartman,C.M. (1996) Mortality update of butadiene production workers. Toxicology, 113, 169-181.
8. National Toxicology Program. (2000) Report on Carcinogens, 9th edn. United States Department of Health and Human Services, Public Health Service, National Toxicology Program, Research Triangle Park, NC.
9. IARC (1999) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, Lyon, Vol. 71, pp. 109-225.
10. USEPA (2002) Health Assessment of 1,3-Butadiene, Publication 600/ P-98/001F. United States Environmental Protection Agency National Center for Environmental Assessment, Washington DC.
11. Malvoisin,E. and Roberfroid,M. (1982) Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica, 12, 137-144.
12. Cśanady,G.A., Guenergerich,F.P. and Bond,J.A. (1992) Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats, and mice. Carcinogenesis, 13, 1143-1153.
13. Cheng,X. and Ruth,J.A. (1993) A simplified methodology for quantitation of butadiene metabolites. Application to the study of 1,3-butadiene metabolism by rat liver microsomes. Drug Metab. Dispos., 21, 121-124.
14. Krause,R.J., Sharer,J.E. and Elfarra,A.A. (1997) Epoxide hydrolase-dependent metabolism of butadiene monoxide to 3-butene-1,2-diol in mouse, rat, and human liver. Drug Metab. Dispos. 25, 1013-1015.
15. Krause,R.J., Kemper,R.A. and Elfarra,A.A. (2001) Hydroxymethylvinyl ketone: A reactive Michael acceptor formed by the oxidation of 3-butene-1,2-diol by cDNA-expressed human cytochrome P450s and mouse, rat, and human liver microsomes. Chem. Res. Toxicol., 14, 1590-1595.
16. Kemper,R.A., Elfarra,A.A. and Myers,S.R. (1998) Metabolism of 3-butene-1,2-diol in B6C3F1 mice. Drug Metab. Dispos., 26, 914-920.
17. Kemper,R.A. and Elfarra,A.A. (1996) Oxidation of 3-butene-1,2-diol by alcohol dehydrogenase. Chem. Res. Toxicol., 9, 1127-1134.
18. Sabourin,P.J., Burka,L.T., Bechtold,W.E., Dahl,A.R., Hoover,M.D., Chang,I.Y. and Henderson,R.F. (1992) Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4(N acetyl-cysteinyl) butane, a novel metabolite of butadiene. Carcinogenesis, 13, 1633-1638.
19. Bechtold,W.E., Strunk,M.R., Chang,I.Y., Ward,J.B. and Henderson,R.F. (1994) Species differences in urinary butadiene metabolites: Comparisons of metabolite ratios between mice, rats, and humans. Toxicol. Appl. Pharmacol., 127, 44-49.
20. Richardson,K.A., Peters,M.C.G., Megens,R.H.J.J.J., van Elburg,P.A., Golding,B.T., Boorgaard,P.J., Watson,W.P. and van Sittert,N.J. (1998) Identification of novel metabolites of butadiene monoepoxide in rats and mice. Chem. Res. Toxicol., 11, 1543-1555.
21. 14C-1,3-butadiene in rats and mice: relevance to cancer susceptibility. Toxicol. Sci., 49, 186-201.
22. Sprague,C.L. and Elfarra,A.A. (2004) Mercapturic acid urinary metabolites of 3-butene-1,2-diol as in vivo evidence for the formation of hydroxymethylvinyl ketone in mice and rats. Chem. Res. Toxicol., 17, 819-826.
23. Cochrane,J.E. and Skopek,T.R. (1994) Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis, 15, 713-717.
24. Cochrane,J.E. and Skopek,T.R. (1994) Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hrpt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis, 15, 719-723.
25. Walker,V.E., Walker,D.M., Meng,Q., McDonald,J., Scott,B.R., Bauer,M.J., Claffey,D.J., Powley,M.W., Upton,P.B., Swenberg,J.A. and Henderson,R.F. (2005) Genotoxicity of 1,3-butadiene and its epoxy intermediates. Res. Rep. Health Eff. Inst., in press.
26. Walker,V.E. and Meng,Q. (2000) 1,3-Butadiene: Cancer, mutations, and adducts. Part III. In vivo mutation of the endogenous hprt genes of mice and tats by 1,3-butadiene and its metabolites. Res. Rep. Health Eff. Inst., 92, 89-139.
27. Sprague,C.L., Phillips,L.A., Young,K.M. and Elfarra,A.A. (2004) Species and tissue differences in the toxicity of 3-butene-1,2-diol in male Sprague-Dawley rats and B6C3F1 mice. Toxicol. Sci., 80, 3-13.
28. Filser,J.G., Faller,T.H., Bhowmik,S., Schuster,A., Kessler,W., Putz,C. and Csanády,G.A. (2001) First-pass metabolism of 1,3-butadiene in once-through perfused livers of rats and mice. Chem.-Biol. Interact. 135-136, 249-265.
29. 13C]butadiene. Chem. Res. Toxicol., 9, 764-773.
30. Eder,E., Scheckenbach,S., Deininger,C. and Hoffman,C. (1993) The possible role of α,β-unsaturated carbonyl compounds in mutagenesis and carcinogenesis. Toxicol. Lett., 67, 87-103.
31. Powley,M.W., Jayaraj,K., Gold,A., Ball,L.M. and Swenberg,J.A. (2003) 1,N2-propanodeoxyguanosine adducts of the 1,3-butadiene metabolite, hydroxymethylvinyl ketone. Chem. Res. Toxicol., 16 1448-1454.
32. Tretyakova,N.Y., Chiang,S.Y., Walker,V.E. and Swenberg,J.A. (1998) Quantitative analysis of 1,3-butadiene-induced DNA adducts in vivo and in vitro using liquid chromatography electrospray ionization tandem mass spectrometry. J. Mass. Spec., 33, 363-376.
33. Mowrer,J., Törnqvist,M., Jensen,S. and Ehrenberg,L. (1986) Modified Edman degradation applied to hemoglobin for monitoring occupational exposure to alkylating agents. Toxicol. Environ. Chem., 11, 215-257.
34. Walker,V.E., Fennel,T.R., Upton,P.B., MacNeela,J.P., Skopek,T.R., Shuker,D.E.G. and Swenberg,J.A. (1992) Molecular dosimetry of ethylene oxide: Formation and persistence of N-(2-hydroxyethyl)valine in hemoglobin following repeated exposures of rats and mice. Cancer Res. 52, 4328-4334.
35. Törnqvist,M., Mowrer,J., Jensen,S. and Ehrenberg,L. (1986) Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal. Biochem., 154, 255-266.
36. Upton,P.B., Ranasinghe,A., Walker,V.E. and Swenberg,J.A. (2000) Formation of hemoglobin adducts in female rats and mice exposed to butadiene. Toxicologist, 54, 1442.
37. Koc,H., Tretyakova,N.Y., Walker,V.E., Henderson,R.F. and Swenberg,J.A. (1999) Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene. Chem. Res. Toxicol., 12, 566-574.
38. 14C]-1,3-butadiene. Chem.-Biol. Interact., 148, 69-92.
39. 14C]-butadiene. Chem.-Biol.-Interact., 147, 195-211.
40. 14C] -butadiene. Chem. Biol. Interact., 147, 213-232.
41. Swenberg,J.A., Koc,H., Upton,P.B., Georguieva,N., Ranasinghe,A., Walker,V.E. and Henderson,R. (2001) Using DNA and hemoglobin adducts to improve the risk assessment of butadiene. Chem.-Biol. Interact., 135-146, 387-403.
42. Oe,T., Kambouris,S.J., Walker,V.E., Meng,Q., Recio,L., Wherli,S., Chaudhary,A.K. and Blair,I.A. (1999) Persistence of N -(2,3,4-trihydroxybutyl)guanine adducts in the livers of mice and rats exposed to 1,3-butadiene. Chem. Res. Toxicol., 12, 247-257.
43. Himmelstein,M.W., Asgharian,B. and Bond,J.A. (1995) High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Toxicol. Appl. Pharmacol., 132, 281-288.
44. Thornton-Manning,J.R., Dahl,A.R., Bechtold,W.E., Griffith,W.C. and Henderson,R.F. (1995) Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis, 16, 1723-1731.
45. Himmelstein,M.W., Turner,M.J., Asgharian,B. and Bond,J.A. (1994) Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis, 15, 1479-1486.
46. Meng,Q., Henderson,R.F., Chen,T., Heflic,R.H., Walker,D.M., Bauer,M.J., Reilly,A.A. and Walker,V.E. (1999) Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats. Mutat. Res., 429, 107-125.
47. Meng,Q., Henderson,R.F., Walker,D.M., Bauer,M.J., Reilly,A.A. and Walker,V.E. (1999) Mutagenicity of the racemic mixtures of butadiene monoepoxide and butadiene diepoxide at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats. Mutat. Res., 429, 127-140.
48. Engelward,B.P., Boosalis,M.S., Chen,B.J., Deng,Z., Siciliano,M. and Samson,L.D. (1993) Cloning and characterization of a mouse 3-methyladenine/7-methyl-guanine/3-methylguanine DNA glycosylase cDNA whose gene maps to chromosome 11. Carcinogenesis, 14, 175-181.
49. Engelward,B.P., Weeda,G., Wyatt,M.D., Broekhof,J.L.M., De Wit,J., Donker,I., Allan,J.M., Gold,B., Hoeijmakers,J.H.J. and Sampson,L.D. (1997) Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc. Natl Acad. Sci. USA, 94, 13087-13092.
50. Koivisto,P., Kilpelainen,I., Rasanen,I., Adler,I.D., Pacchierto,F. and Peltonen,K. (1999) Butadiene diolepoxide-diepoxybutane-derived DNA adducts of N7-guanine: A high occurrence of diolepoxide-derived adducts in mouse lung after 1,3-butadiene exposure. Carcinogenesis 20, 1253-1259.
51. Perez,H.L., Lahdetie,J., Landin,H.H., Kilpelainen,I., Koivisto,P., Peltonen,K. and Osterman-Golkar,S. (1997) Haemoglobin adducts of epoxybutanediol from exposure to 1,3-butadiene or butadiene epoxides. Chem.-Biol. Interact., 105, 181-198.
52. Meng,Q., Henderson,R.F., Long,L., Blair,L., Walker,D.M., Upton,P.B., Swenberg,J.A. and Walker,V.E. (2001) Mutagenicity at the Hprt locus in T cells of female mice following inhalation exposures to low levels of 1,3-butadiene. Chem.-Biol. Interact., 135-136, 343-361.